Use of In Vitro–In Vivo Correlation to Predict the Pharmacokinetics of Several Products Containing a BCS Class 1 Drug in Extended Release Matrices

[1]  S. Qureshi.  In Vitro-In Vivo Correlation (IVIVC) and Determining Drug Concentrations in Blood from Dissolution Testing A Simple and Practical Approach~!2009-10-30~!2010-01-04~!2010-04-29~! , 2010 .

[2]  S. Qureshi.  In Vitro-In Vivo Correlation (IVIVC) and Determining Drug Concentrations in Blood from Dissolution Testing - A Simple and Practical Approach , 2010 .

[3]  P. Veski,et al.  Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release , 1998, European Journal of Drug Metabolism and Pharmacokinetics.

[4]  Raimar Löbenberg,et al.  Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  H. Junginger.  Excipients as Absorption Enhancers , 2008 .

[6]  D. Burgess,et al.  In Vitro–In Vivo Correlation on Parenteral Dosage Forms , 2008 .

[7]  S. Fitzpatrick,et al.  Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. , 2007, International journal of pharmaceutics.

[8]  T. Smart,et al.  Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo-in vitro correlation (IVIVC). , 2004, Journal of pharmaceutical sciences.

[9]  Davide Verotta,et al.  Volterra Series in Pharmacokinetics and Pharmacodynamics , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  Yi Tsong,et al.  In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 , 1998, Pharmaceutical Research.

[11]  Patrick Marroum,et al.  Development and Internal Validation of an In Vitro-in Vivo Correlation for a Hydrophilic Metoprolol Tartrate Extended Release Tablet Formulation , 1998, Pharmaceutical Research.

[12]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[13]  A S Hussain,et al.  Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate. , 2000, Journal of pharmaceutical sciences.

[14]  P. Veski,et al.  Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations. , 1999, International journal of pharmaceutics.

[15]  N. Chidambaram,et al.  Formulation and characterization of new layered diffusional matrices for zero-order sustained release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[16]  J. W. Moore,et al.  Mathematical comparison of dissolution profiles , 1996 .

[17]  B. Rohrs,et al.  USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. , 1995, Journal of pharmaceutical sciences.